Danaher Corp (WBO:DHRC)
€ 224.85 4.45 (2.02%) Market Cap: 161.28 Bil Enterprise Value: 175.38 Bil PE Ratio: 45.34 PB Ratio: 3.35 GF Score: 84/100

Danaher Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 07:15PM GMT
Release Date Price: €219.8 (+3.73%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. This is Rachel Vatnsdal from the life science tools and diagnostics team here at JPMorgan. Thank you for coming to the Danaher presentation. This will be a 40-minute session as we typically do, roughly 20 minutes of our presentation followed by 20 minutes of Q&A. If you do have questions, feel free to either submit them via the app or you can ping me directly. And with that, I will pass it off to Rainer.

Rainer M. Blair
Danaher Corporation - President, CEO & Director

Well, thank you, Rachel, and thank you to JPMorgan for having us, and good morning, everybody, and thank you for joining us today. Before I jump into my presentation, just a quick look at our forward-looking statement advisory here, which you can cruise along with our non-GAAP reconciliation schedule at your own leisure. Now let me get started with just a brief update as to our preliminary results for the fourth quarter of 2023.

Our core growth came in better than expected.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot